SEC 13F Intelligence

Cloverfields Capital Group, LP / TMO

Cloverfields Capital Group, LP’s Thermo Fisher Scientific Inc Position

Does Cloverfields Capital Group, LP own Thermo Fisher Scientific Inc (TMO)? Not currently — the last reported position was 8.8K shares worth $5M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q4 2025
Shares
8.8K
% of Portfolio
+1.57%
Quarters Held
9
position exited

Position History TMO

Reported value by quarter
Q4 ’23: $5MQ4 ’23Q1 ’24: $6MQ2 ’24: $6MQ2 ’24Q3 ’24: $6MQ4 ’24: $5MQ4 ’24Q1 ’25: $5MQ2 ’25: $4MQ2 ’25Q3 ’25: $4MQ4 ’25: $5MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20258.8K$5M+1.57%
Q3 20259.2K$4M+1.39%
Q2 20259.3K$4M+1.12%
Q1 20259.5K$5M+1.56%
Q4 20249.9K$5M+1.65%
Q3 20249.9K$6M+1.97%
Q2 202410.7K$6M+1.99%
Q1 202410.8K$6M+2.11%
Q4 202310.2K$5M+2.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cloverfields Capital Group, LP’s full portfolio or all institutional holders of TMO.